NEW YORK and TORONTO, March 12, 2026 (GLOBE NEWSWIRE) -- Helus PharmaTM (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today announced the appointment…
Proven human resources and organizational strategist brings more than two decades of leadership across the pharmaceutical industry
Appointment supports Helus Pharmas continued maturat… [+8086 chars]